Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Sexuality 1Sexual Dysfunction, Physiological 1Radiation Injuries 1Prostatic Neoplasms 1Erectile Dysfunction 1

Interventions

Psychiatric Rehabilitation 4Surveys and Questionnaires 3Radiotherapy 3Counseling 3Sildenafil Citrate 2methyl N-acetylsibirosaminide 1methyl 3-mercaptopropionimidate 1bicalutamide 1Vitamin D 1Therapeutics 1Testosterone Propionate 1Testosterone 1Tadalafil 1Surgical Procedures, Operative 1Restraint, Physical 1Radiosurgery 1Prostatectomy 1Pilocarpine 1Phenylephrine 1Phentolamine 1Papaverine 1Nutrition Assessment 1Mindfulness-Based Stress Reduction 1Menogaril 1Magnetic Resonance Spectroscopy 1Low Density Lipoprotein Receptor-Related Protein-1 1Leuprolide 1Interviews as Topic 1Hormonal Contraception 1High-Intensity Focused Ultrasound Ablation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Sexual Dysfunction, Physiological × ArginMax × Clear all
NCT00459134 2021-09-28

L-Arginine Supplements in Treating Women Who Are Cancer Survivors

Wake Forest University Health Sciences

Phase NA Completed
186 enrolled 11 charts
Other

Sexual Dysfunction, Physiological, Sexuality

Data powered by HemOnc (CC BY 4.0) Colophon âš¡